The EGFR/ErbB inhibitor neratinib modifies the neutrophil phosphoproteome and promotes apoptosis and clearance by airway macrophages
Authors:
Open Access
- 28 July 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 956991
Abstract
Dysregulated neutrophilic inflammation can be highly destructive in chronic inflammatory diseases due to prolonged neutrophil lifespan and continual release of histotoxic mediators in inflamed tissues. Therapeutic induction of neutrophil apoptosis, an immunologically silent form of cell death, may be beneficial in these diseases, provided that the apoptotic neutrophils are efficiently cleared from the tissue. Previous research in our group identified ErbB inhibitors as able to induce neutrophil apoptosis and reduce neutrophilic inflammation bothin vitroandin vivo. Here, we extend that work using a clinical ErbB inhibitor, neratinib, which has the potential to be repurposed in inflammatory diseases. We show that neratinib reduces neutrophilic migration o an inflammatory site in zebrafish larvae. Neratinib upregulates efferocytosis and reduces the number of persisting neutrophil corpses in mouse models of acute, but not chronic, lung injury, suggesting that the drug may have therapeutic benefits in acute inflammatory settings. Phosphoproteomic analysis of human neutrophils shows that neratinib modifies the phosphorylation of proteins regulating apoptosis, migration, and efferocytosis. This work identifies a potential mechanism for neratinib in treating acute lung inflammation by upregulating the clearance of dead neutrophils and, through examination of the neutrophil phosphoproteome, provides important insights into the mechanisms by which this may be occurring.Keywords
All Related Versions
Funding Information
- Medical Research Council
- Rosetrees Trust
- University of Sheffield
This publication has 61 references indexed in Scilit:
- Elastase/LPS-Exposed Mice Exhibit Impaired Innate Immune Responses to Bacterial ChallengeThe American Journal of Pathology, 2012
- Congenital neutropenia: diagnosis, molecular bases and patient managementOrphanet Journal of Rare Diseases, 2011
- Rhinovirus induces MUC5AC in a human infection model andin vitroviaNF-κB and EGFR pathwaysEuropean Respiratory Journal, 2010
- The LTB4-BLT1 Axis Mediates Neutrophil Infiltration and Secondary Injury in Experimental Spinal Cord InjuryThe American Journal of Pathology, 2010
- Neutrophil Apoptosis: Relevance to the Innate Immune Response and Inflammatory DiseaseJournal of Innate Immunity, 2010
- NPM phosphorylation stimulates Cdk1, overrides G 2 /M checkpoint and increases leukemic blasts in miceCarcinogenesis, 2009
- Dysregulated apoptosis and NFκB expression in COPD subjectsRespiratory Research, 2009
- The effect of tiotropium therapy on markers of elastin degradation in COPDRespiratory Research, 2009
- Journey to the grave: signaling events regulating removal of apoptotic cellsJournal of Cell Science, 2007
- Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.Journal of Clinical Investigation, 1998